Genomic organisation and expression of BCL6 in murine B-cell lymphomas

Leukemia Research

Volumn 24, Issue 8, 2000, Pages 719-732

  Qi, Chen Feng ^a   Hori, Mitsuo ^a   Coleman, Allen E ^b   Torrey, Ted A ^a   Taddesse Heath, Lekidelu ^a   Ye, B Hilda ^c   Chattopadhyay, Sisir K ^a   Hartley, Janet W ^a   Morse Iii, H C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

BCL6; Mouse B cell lymphoma; Spectral karyotyping; Translocation

Indexed keywords

PROTEIN BCL 6; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL MODEL; B CELL LYMPHOMA; CHROMOSOME 16; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETIC CODE; GENETIC ORGANIZATION; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LARGE CELL LYMPHOMA; LYMPHOMA CELL LINE; METAPHASE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVIEW; SOUTHERN BLOTTING;

EID: 0033915417     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(00)00028-X     Document Type: Article

References (60)

1. Ye B.H., Rao P.H., Chaganti R.S., Dalla-Favera R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res. 53:1993;2732-2735.
2. Kerckaert J.-P., Deweindt C., Tilly H., Quief S., Lecocq G., Bastard C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphoma. Nat. Genet. 5:1993;66-70.
3. Baron B.W., Nucifora G., McCabe N., Espinosa R., LeBeau M.M., McKeithan T.W. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc. Natl. Acad. Sci. USA. 90:1993;5262-5266.
4. Ye B.H., Lista F., LoCoco F., Knowles D.M., Offit K., Chaganti R.S.K., Dalla-Favera R. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 262:1993;747-750.
5. LoCoco F., Ye B.H., Lista F., Corradini P., Offit K., Knowles D.M. et al. Rearrangements of the BCL-6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood. 83:1994;1757-1759.
6. Bastard C., Deweindt C., Kerckaert J.P., Lenormand B., Rossi A., Peaaclia F. et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood. 83:1994;2423-2427.
7. Otsuki T., Yano T., Clark H.M., Bastard C., Kerckaert J.P., Jaffe E.S. et al. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood. 85:1995;2877-2884.
8. Gaidano G., Pastore C., Migliazza A., Gloghini A., Saglio G., Carbone A. et al. Involvement of the Bcl-6 gene in AIDS-related lymphomas. Ann. Oncol. 8:1997;5105-5108.
9. Migliazza A., Martinotti S., Chen W., Fusco C., Ye B.H., Knowles D.M. et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc. Natl. Acad. Sci. USA. 92:1995;12520-12524.
10. Gaidano G., Carbone A., Pastore C., Capello D., Migliazza A., Gloghini A. et al. Frequent mutation of the 5′ noncoding region of the BCL6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood. 89:1997;3755-3762.
11. Capello D., Vitolo U., Pasqualucci L., Quattrone S., Migliaretti G., Fassone L. et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood. 95:2000;651-659.
12. + anaplastic large-cell lymphomas. Blood. 90:1997;2445-2450.
13. Onizuka T., Moriyama M., Yamochi T., Kuroda T., Kazama A., Kanazawa N. et al. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B-cells and their neoplastic counterparts. Blood. 86:1995;28-37.
14. Allman D., Jain A., Dent A., Maile R.R., Selvaggi T., Kehry M.R. et al. BCL-6 expression during B-cell activation. Blood. 87:1996;5257-5268.
15. Falini B., Fizzotti M., Pileri S., Liso A., Pasqualucci L., Flenghi L. BCL-6 protein expression in normal and neoplastic lymphoid tissues. Ann. Oncol. 8:1997;101-104.
16. Cattoretti G., Chang C.-C., Cechova K., Zhang J., Ye B.H., Falini B. et al. BCL-6 protein is expressed in germinal-center B-cells. Blood. 86:1995;45-53.
17. Qi C.-F., Jessberger R., Torrey T.A., Taddesse-Heath L., Ohta Y., Morse III H.C. Differential regulation of germinal center genes, BCL6 and SWAP-70, during the course of MAIDS. Mol. Immunol. 36:1999;1043-1053.
18. Zheng B., Han S., Kelsoe G. T helper cells in murine germinal centers are antigen-specific emigrants that downregulate Thy-1. J. Exp. Med. 184:1996;1083-1091.
19. Moriyama M., Yamochi T., Semba K., Akiyama T., Mori S. BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo. Oncogene. 14:1997;2465-2474.
20. Chang C.-C., Ye B.H., Chaganti R.S.K., Dalla-Favera R. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcription repressor. Proc. Natl. Acad. Sci. USA. 93:1996;6947-6952.
21. Seyfert V.L., Allman D., He Y., Staudt L.M. Transcriptional repression by the protooncogene, BCL-6. Oncogene. 12:1996;2331-2342.
22. Deweindt C., Albagli O., Bernardin F., Dhordain P., Quief S., Lantoine D. et al. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Cell. Growth. Differ. 6:1995;1495-1503.
23. Dent A.L., Shaffer A.L., Yu X., Allman D., Staudt L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science. 276:1997;589-592.
24. Fredrickson T.N., Morse III H.C., Rowe W.P. Spontaneous tumours of NFS mice congenic for ecotropic murine leukemia virus induction loci. J. Natl. Cancer. Inst. 73:1984;521-524.
25. Fredrickson T.N., Hartley J.W., Morse III H.C., Chattopadhyay S.K., Lennert K. Classification of mouse lymphomas. Curr. Top. Microbiol. Immunol. 194:1995;109-116.
26. Fredrickson T.N., Lennert K., Chattopadhyay S.K., Morse III H.C., Hartley J.W. Splenic marginal zone lymphomas of mice. Am. J. Pathol. 154:1999;805-812.
27. Hartley JW, Chattopadhyay SK, Lander MR, Taddesse-Heath L, Naghashfar Z, Morse III HC, et al. Accelerated appearance of multiple B-cell lymphoma types in NFS/N mice congenic for ecotropic murine leukemia viruses, Lab Invest 2000;80:159-169.
28. Morse III H.C., Qi C.-F., Taddesse-Heath L., Chattopadhyay S.K., Ward J.M., Coleman A. et al. Novel aspects of murine B-cell lymphomas. Curr. Topics. Microbiol. Immunol. 246:1999;249-264.
29. Taddesse-Heath L, Morse III HC. Lymphoma in genetically engineered mice. In: Ward JM, Mahler J, Maronpot RR, Sundberg JP, Fredrickson R, editors. Pathology of genetically engineered mice. Ames, Iowa: Iowa State University Press (in press).
30. Jaffe E.S., Harris N.L., Diebold J., Muller-Hermelink H.-K. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: a progress report. Am. J. Clin. Pathol. 111:1999;S8-S12.
31. + lineage of B lymphocyte differentiation. J. Immunol. 133:1984;744-753.
32. Mushinski J.F., Davidson W.F., Morse III H.C. Activation of cellular oncogenes in human and mouse leukemia-lymphomas: spontaneous and induced oncogene expression in murine B lymphocytic neoplasms. Cancer. Invest. 5:1987;345-368.
33. Klinken S.P., Fredrickson T.N., Hartley J.W., Yetter R.A., Morse III H.C. Evolution of B-cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. J. Immunol. 140:1988;1123-1131.
34. Paige C.J., Kincade P.W., Ralph P. Murine B-cell leukemia line with inducible surface immunoglobulin expression. J. Immunol. 121:1978;641-647.
35. Kim K.J., Kanellopoulos-Langevin C., Merwin R.M., Sachs D.H., Asofsky R. Establishment and characterization of BALB/c lymphoma lines with B-cell properties. J. Immunol. 122:1979;549-554.
36. Nicolas J.-F., Wegmann D., Lebrun P., Kaiserlian D., Tovey J., Glasebrook A.L. Relationship of B-cell Fc receptors to T-cell recognition of Mls antigen. Eur. J. Immunol. 17:1987;1561-1565.
37. Lanier L.L., Warner N.L. Cell cycle related heterogeneity of Ia antigen expression on a murine B lymphoma cell line: analysis by flow cytometry. J. Immunol. 126:1981;626-631.
38. Qi C.-F., Chattopadhyay S.K., Lander M., Kim Y., Fredrickson T.N., Hartley J.W. et al. Expression of cyclin D1 in mouse B-cell lymphomas of different histologic types and differentiation stages. Leuk. Res. 22:1998;395-404.
39. NIH Website. Radiation safety branch. http://rsb.info.nih.gov/nih-image/index.html [7 January 2000 last date accessed].
40. Bernardin F., Collyn-d'Hooghe M., Quief S., Bastard C., Leprince D., Kerckaert J.-P. Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation. Oncogene. 14:1997;849-855.
41. Chattopadhyay S.K., Lander M.R., Rands E., Lowy D.R. Structure of endogenous murine leukemia virus DNA in mouse genomes. Proc. Natl. Acad. Sci. USA. 77:1980;5774-5778.
42. Chomczynski P., Sacci N. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Ann. Biochem. 162:1987;156-159.
43. Liyanage M., Coleman A., duManoir S., Veldman T., McCormack S., Dickson R.B. et al. Multicolour spectral karyotyping of mouse chromosomes. Nat. Genet. 14:1996;312-315.
44. Schrock E., duManoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A. et al. Multicolor spectral karyotyping of human chromosomes. Science. 273:1996;494-497.
45. Coleman A.E., Schrock E., Weaver Z., duManoir S., Yang F., Ferguson-Smith M.A. et al. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping. Cancer Res. 57:1997;4585-4592.
46. Rabbitts P., Impey H., Heppell-Parton A., Langford C., Tease C., Lowe N. et al. Chromosome specific paints from a high resolution flow karyotype of the mouse. Nat. Genet. 9:1995;369-375.
47. Lukes RJ, Collins RD. New approaches to the classification of the lymphomata, Br J Cancer 1975;31(Suppl. II):1-28.
48. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K.C., Cleary M.L. et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 84:1994;1361-1392.
49. Lennert K. Histopathology of non-Hodgkin's lymphomas: based on the Kiel Classification. 1981;1981 Springer-Verlag, New York.
50. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.-K., Vardiman J. et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. J. Clin. Oncol. 17:1999;3835-3849.
51. Schlegelberger B., Zwingers T., Harder L., Nowotny H., Siebert R., Vesely M. et al. Lymphoma Study Group. Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Blood. 94:1999;3114-3120.
52. Liao X., Gilbert D.J., Dent A., Staudt L.M., Jenkins N.A., Copeland N.G. Mapping of the mouse Bcl6 gene to chromosome 16. Mamm. Genome. 7:1996;621-622.
53. Flenghi L., Ye B.H., Fizzoti M., Bigerna B., Cattoretti G., Venturi S. et al. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B-cells. Am. J. Pathol. 147:1995;405-411.
54. Ye B.H., Chaganti S., Chang C.-C., Niu H., Corradini P., Chaganti R.S.K. et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B-cell lymphoma. EMBO J. 14:1995;6209-6218.
55. Flenghi L., Bigerna B., Fizzotti M., Venturi S., Pasqualucci L., Pileri S. et al. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL6 protein amino-terminal region. Am. J. Pathol. 148:1996;1543-1555.
56. Mouse Genome Informatics Website. Jackson Laboratory. 29 November 1999. http://www.informatics.jax.org/userdocs/2.3announcement.shtml [7 January, 2000, last date accessed].
57. NIH Website. NCBI. 2 August 1999. http://www.ncbi.nlm.nih.gov/Homology/ [7 January 2000, last date accessed].
58. NCBI Website. June 1998. F. Mitelman, F. Mertens and B. Johansson http://www.ncbi.nlm.nih.gov/CCAP/mitelsum.cgi [7 January 2000, last date accessed].
59. Jakway J.P., Usinger W.R., Gold M.R., Mishell R.I., deFranco A.L. Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products. J. Immunol. 137:1986;2225-2231.
60. Potter M., Wiener F. Plasmacytomas in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis (London). 13:1992;1681-1697.